LIGAND PHARMACEUTICALS INC — Director's Dealing 2015

Mar 18, 2015

SEC Form 4/A — Form 4/A

Issuer: LIGAND PHARMACEUTICALS INC (LGND)
CIK: 0000886163
Period of Report: 2014-12-31

Reporting Person: Berkman Charles S (VP, Gen. Counsel & Secretary)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-12-31	Common Stock	J	126.0	$45.2285	Acquired	27433	Direct

Footnotes

F1: Shares acquired under Ligand's employee stock purchase plan. Voluntary reporting exemption under Rule 16b-3(c).

F2: The Amount of Securities Beneficially Owned is reflected as of the original filing date.